All Articles

Logitech's new Mobi Fold isn't just a clever gadget. It's a strategic assault on the trackpad, aiming to close the productivity gap for hybrid professionals.

A groundbreaking partnership between Servier and n-Lorem Foundation blends pharma R&D muscle with non-profit agility to develop ASO therapies for the rarest of diseases.

A strategic pivot from commercial real estate to the hard assets of the new economy reveals where the smart money is flowing—and it’s not just into buildings.

As new drugs outpace manufacturing capacity, a French giant bets on local production in China to build the supply chains of tomorrow's therapies.

Beyond art and music, China's UN-backed event in Geneva reveals a calculated investment in global influence, aiming to reshape multilateralism itself.

A landmark deal locks in energy for Ukraine and Finland until 2044, cementing a small Baltic terminal as a powerhouse of European strategic resilience.

A new deal to push advanced solar tech into emerging markets is more than a sales win; it's a strategic blueprint for navigating the future of global energy.

Leading Edge Materials confirms a low-cost, high-purity graphite process at its Swedish mine, positioning Woxna to supply Europe's booming EV battery market.

A new campaign pairs a star athlete with a robotic mower, revealing a deeper strategy to win the multi-billion-dollar race for autonomous home care.

A new study by SciBase and Castle Biosciences is testing technology to predict atopic dermatitis flares, promising a shift from reactive care to patient control.

Japanese artist Takuma Tanaka's journey from law to canvas culminates in a Miami exhibition that channels Bruce Lee's wisdom to challenge modern overthinking.

A global health giant is now targeting the world's financial system, arguing that crippling debt is a deadlier crisis than any disease. Is their plan a revolution or a fantasy?

In just two years, AIKO Energy has captured a significant slice of Australia's solar market. We dissect the strategy combining breakthrough tech and local focus.

Metrica Partners' public battle with WUS Printed Circuit exposes a billion-dollar valuation gap, testing Taiwan's new corporate governance reforms.

Biotech firm Sensorion drops one gene therapy to fast-track another, aiming to cure GJB2-related hearing loss, the leading cause of genetic deafness.

A new AI platform from Bell Integration and IBM aims to end IT 'firefighting.' We look under the hood at the tech and strategy driving this major shift.

Sanofi's promising nerve disease drug fails in late-stage trials, leaving vulnerable patients in limbo and highlighting the brutal realities of medical innovation.

Pollo AI's new Commerce Studio promises to slash product visual costs for sellers. But as AI automates the photo shoot, it raises critical questions about creative jobs and consumer trust.

A new routing model promises to solve the persistent liquidity and execution problems plaguing the $31B tokenized asset market. Is this the key?

How a Swedish city's new aquatic center, powered by unique CO₂ technology, reveals a future where public infrastructure can be both sustainable and strategic.